Skip to content
Tenfell
Awarded contract
Published 19 Oct 2021

NHS Framework Agreement for Branded Medicines - National

NHS England · London

Key facts

Awarded
26 Sep 2021
Contract starts
01 Nov 2021
Contract ends
30 Apr 2023
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 37 suppliers

SupplierValue
Takeda UK Limited—
Martindale Pharma—
Orifarm UK—
Pfizer Ltd—
Teva UK Ltd—
Bayer plc—
Aventis Pharma Ltd T/A Sanofi—
Napp Pharmaceuticals—
Qdem Pharmaceuticals—
Sandoz Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Gedeon Richter UK Ltd—
Ipsen—
Kent Pharma Ltd—
Merck Serono Limited—
Mylan—
Novartis Pharmaceuticals UK Ltd—
Zentiva Pharma UK Ltd—
Day Lewis Medical Ltd—
medac Pharma LLP—
Tillomed Laboratories ltd—
FLYNN PHARMA LTD—
Glenmark Pharmaceuticals Europe Ltd—
Aspire Pharma Ltd—
Ferring Pharmaceuticals Limited—
Dexcel Pharma Ltd—
Aspen Pharmacare UK Limited—
Chiesi Limited—
Morningside Pharmaeuticals—
Tetris Pharma Lts—
UL Global Pharma—
Ridge Pharma—
Astellas Pharma Ltd—
Nordic Pharma—
Pharmasure—
Theramex HQ UK—

Description

NHS Framework Agreement for Branded Medicines - National

FIND A TENDER (FTS) Reference number: FTS-002612

Offer reference number: CM/PHR/20/5610

CM/PHR/20/5610/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Period of framework: 1 November 2021 to 31 October 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/20/5610/02 - NHS Framework Agreement for Branded Medicines - National Tender Period of framework: 1 November 2021 to 30 April 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18 months

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.